Stockprowler.com

Our last Stockprowler pick, iDial Networks, inc. (OTC BB: IDNW) spiked 51% after our profile report on November 10… not a bad short-term gain. And long term it looks impressive…. A couple of our recent Stockprowler Watch stocks have done exceedingly well this past week, PCDI peaking at 32 cents up 191% and SBAC hit 72 cents intra-week up 118%. Also, VLVT, our profile pick on September 15 is beginning to show strength again closing out the week up 88%. Our recent pick CMXS is still a waiting game… to those who have emailed us, all we can say is that this is a very speculative investment as we stated in our original report. I also would like to remind readers that Stockprowler.com does not receive compensation from companies we profile or from third parties. When we take a position in any company we profile or mention on our Website we put our own money on the line… that has been our policy from day one back in 1999. We would ask that everyone take a few minutes and read our full disclaimer.

In the Watch Box this week, in addition to previous picks CMXS, IDNW, and VLVT… we like CDED @ 7cents and MMG @ 10 cents. CareDecision Corp. (OTC BB: CDED) with its highly innovative wireless voice command PDA releases the physician, at the point of patient care, from the physical restrictions of paper, pen, keyboard. Information can be downloaded, directives issued, medical orders placed, results recorded and therapies electronically transmitted during the course of an examination while the physician's hands and eyes remain focused on the patient's care. MD@Command(TM) enables the verbal request of patient histories, formulary and dangerous drug interaction data, construction of medical prescription and clinical lab tests, recording of therapies and the electronic transmission of physician directives… And keep your eyes on Metromedia Int.Group. (Amex: MMG) re-structuring efforts seem to be gaining approval with investors… up 25% this week. It’s early yet, but could be a momentum play developing here.

Stockprowler’s pick this week...

NatureWell, Inc. (OTC BB: NAWL)
7855 Ivanhoe Avenue, Suite 322
La Jolla, CA 92037
CEO: James Arabia
Phone: (858) 454-6790
Fax: (858) 454-7851
Website: http://www.migraspray.com/
Shares Outstanding: 104.6 million
Public Float: 58.6 million
Market Capitalization: $2.82 million
Closing Price Friday 11/22/02: 2.7 cents

An estimated 32 million Americans suffer from migraine headaches that can last from a few hours to as long as 3 days or more. Symptoms, which are often debilitating, may include intense pain, throbbing, nausea, sensitivity to light and sounds, disturbed vision, and slurred speech. Migraines are thought to be caused by a number of things including stress, anxiety, depression, sensitivity to particular foods/ food additives, and alcohol. Hormonal changes in the body are also common triggers. Many women experience migraines with changes in their estrogen levels during menstruation.

Our pick this week, NatureWell, Inc. (OTC BB: NAWL) has recently marketed a homeopathic over-the-counter drug for use in the treatment and prevention of migraine headaches. The proprietary product, Migraspray ®, provides fast relief from migraines and other types of headaches without side effects. Migraspray ® is a clinically tested, patented, homeopathic drug for the fast relief and prevention of the symptoms of migraine headaches and it is now available coast to coast in over 14,000 locations including Walgreen’s, Rite Aid, CVS Drug Stores, Sav-On, Osco, Jewel/Osco, Longs and many supermarkets. On November 5, the popular news weekly, National Enquirer, ran a very positive article on Migraspray ® captioned, “Now You Can Spray Away Your Migraine”. The piece quoted Dr. Cathleen London of the prestigious Tufts University School of Medecine stating, “I am very excited about this new migraine treatment. It is safe, very promising, and I believe it can help millions of people who suffer from these debilitating and painful headaches.” Dr. London has been treating migraine patients for nearly 2 years with Migraspray ®.

Migraspray ® is sprayed under the tongue (sublingual administration), which promotes rapid metabolization by directly entering the bloodstream through the mucous membrane. This fast-acting delivery system allows Migraspray ® to provide rapid relief from migraine pain and other associated symptoms. A recent clinical study showed Migraspray ® can stop migraine headaches in some people in under 7 minutes. Migraspray ® has also been effective in alleviating pain and symptoms associated with menstrual cycles as well as tension headaches and hangovers from a night of celebrating.

Migraspray ® contains the active ingredients feverfew (its primary ingredient), polyporus, goldenseal and dandelion. Feverfew has been used for centuries for the treatment of a variety of ailments, including headaches, rheumatic aches, abdominal pain and menstrual cramps. Studies have shown that feverfew acts as a natural anti-inflammatory, controlling the inflammation that results in cerebral blood vessel dilation, believed to cause or contribute to the symptoms of migraine headaches. The active ingredients in feverfew are sesquiterpene lactones, the primary component being parthenolide, a phyto-chemical. When taken daily for prevention, Migraspray ® has also been shown to be effective in reducing the frequency of migraine headaches.

On October 4, 2002 NatureWell, Inc., announced that it had reached an agreement with Morgan & Sampson Pacific to act as its national master broker. Morgan & Sampson Pacific www.msp-direct.com, headquartered in Los Alamitos, California will provide national sales and marketing services for MIGRASPRAY®, on an exclusive basis, and will distribute the migraine relief product to food, drug and mass retailer channels of distribution throughout the United States. Morgan & Sampson Pacific was involved with the national launch of the incredibly successful Breath-Right nasal strips and provides representation in 11 states for Sea & Ski suntan lotion, Cosamin DS (a glucosamine/chondroitin product for joint relief), and Radicool (AUS) protective swimwear.

Chip Carter, CEO of Morgan & Sampson Pacific stated; “Over the years we've been fortunate to help with the national launch of innovative products such as Breath-Right nasal strips and we feel MIGRASPRAY ® has the potential to eclipse that product's success. In our view MIGRASPRAY ® is a revolutionary product that is safe and highly effective. We look forward to helping NatureWell raise national awareness and extend market penetration of MIGRASPRAY ®.”

NatureWell, Inc. has developed other products using its proprietary Micromist technology including Allerspray, designed for the fast relief of allergy symptoms, without drowsiness, dry-mouth or other side effects. Also under development using the Micromist technology are an anti-inflammatory treatment for the symptoms of arthritis, a natural tranquilizer and several vision-related (non-Micromist) formulations. For the fiscal year ended 6/30/02, net sales totaled $1.2 million, up from $21 thousand. NatureWell, Inc. had gross sales totaling $377,000 for the three month period ended September 30, 2002, compared with $254,942 in gross sales for the same period last year.

For more information on the treatment, visit the Web site www.migraspray.com or call the company toll-free 1-800-711-8357. MigraSpray is available in pharmacies throughout the U.S at a very reasonable price.

NatureWell, Inc. (OTC BB: NAWL) appears to be an undiscovered gem at the present time. It is thinly traded (average daily volume 154,000 shares) and is very volatile moving dramatically on sudden volume changes. Could be a boomer in the making here. Remember you saw it first at Stockprowler.com… Stockprowler.com did not receive compensation of any kind from the company or third parties for writing this report. Readers are urged to read the company SEC filings and do their own due diligence before investing in this or any other stock mentioned on this website.

Good Trading... Stockprowler